https://tudcachemical.com/ocul....ar-fundus-irregulari
The placebo was matched to serelaxin on appearance and management protocol to produce and maintain blinding. The primary endpoint ended up being the change from baseline in fasting HVPG after 2 h of peripheral i.v. serelaxin infusion (80 μg/kg/day for 60 min followed by 30 μg/kg/day for at the very least 60 min). Secondary endpoints included the alteration from baseline in hepatic blood circulation and systemic haemodynamics (cardiac index, sysorded 12 adve
Like
Comment
Share
